Position in SPRO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,094,867
-$687,942 QoQ
Shares Held
947,904
-20.3% QoQ
Ownership
1.63%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 59 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SPRO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. SPRO ranks #130 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in SPRO
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,094,867 | 947,904 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,782,809 | 1,189,235 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,981,286 | 1,279,522 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,731,198 | 1,452,765 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,413,278 | 832,165 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $699,053 | 970,907 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,138,758 | 1,105,591 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,306,035 | 974,653 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,268,737 | 975,952 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,469,671 | 854,460 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $804,773 | 547,465 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $662,069 | 547,165 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $860,474 | 593,431 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $594,935 | 410,300 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $593,217 | 342,900 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $429,400 | 214,700 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $695,811 | 939,017 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $949,170 | 109,100 | Shares | Sole | 2022-05-13 | |
| 2020-09-30 | $1,709,745 | 153,203 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $4,463,587 | 329,903 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,620,368 | 324,303 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||